new indications for glp-1 drugs Drugs: Where We Are and Where We're Going — Summit Re GLP-1 drugs likely to be
Description
doi: 10.1177/1060028017689878 64 Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus
Semaglutide is also under clinical trials for NASH, Alzheimers disease
Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C
Many patients find it faster and more cost-effective to order baseline labs directly, particularly when they want results quickly and dont want to navigate referral processes or insurance prior authorization
